| Acquired by | Boston Scientific |
| Price | $444M |
| Date | 9/10 |
| Website | asthmatx.com |
| @BTforAsthma | |
| Category | BioTech |
| Phone | 408-419-0100 |
| info@asthmatx.com | |
| Employees | |
| Founded | 2003 |
| Description | Medical Devices |
| TOTAL | $50M |
| FUNDING TOTAL | $50M |
| Venture Round, 5/07 | $50M |
Asthmatx, Inc., a medical device company, focuses on developing and commercializing a therapeutic treatment for asthma in the United States. The company has developed a technology that is designed to deliver controlled thermal energy to the airways of adult patients to reduce the mass of airway smooth muscle in a procedure called Bronchial Thermoplasty. Asthmatx offers an interventional medical device, called the Alair System, for the bronchoscopic treatment of patients with moderate to severe asthma.
Asthmatx was founded in 2003 and is headquartered in Mountain View, California. As of October 26, 2010, Asthmatx operates as a wholly-owned subsidiary of Boston Scientific.
